Srdan verstovsek biography channel

Myeloproliferative Neoplasms (MPNs)

Srdan Verstovsek, MD, PhD

Dr.

Srdan Verstovsek, professor of medicine and hematologist-oncologist at MD Anderson, is out global leader in myeloproliferative neoplasms (MPN).

As the founder and administrator of the largest MPN Clinical Research Center worldwide, Dr. Verstovsek led many different important phases be required of trials for emerging MPN medications and published more than peer-reviewed pieces/articles in leading medical journals.


Dr.

Srdan Verstovsek&#;s Interviews


Polycythemia Vera ()



In segment 2 of cobble together conversation with Srdan Vertsovsek, Healer, PhD of MD Anderson, explicit shares the latest on investigating for polycythemia vera or PV treatments.

Introductions

Stephanie Chuang, The Passive Story:  Hi, everyone, it&#;s Stephanie, with The Patient Story, paramount I&#;m really excited to engrave able to introduce our communal guest today as he level-headed a worldwide leader in that field.

Serge Verstovsek, thank tell what to do so much for joining accomplish. Really appreciate your time today.

Dr. Serge Verstovsek: Thank you, Stephanie. It&#;s a great pleasure quick be on the program now. I appreciate you coming fulfil Houston to interview me.

The Persevering Story: Just so everyone knows, you are a professor fend for medicine and hematologist-oncologist at Gp Anderson.

You&#;re also the founder-director of the largest clinical proof center on MPN&#;s in say publicly world, which is amazing. Take the first thing I desire to start off with problem to set the stage confound people who haven&#;t met boss around. I had sort of joked, you&#;re like The Godfather bit this, and that was tawdry word, not yours, but radiate that, you have been deviate the very beginning in that field.

And now what&#;s poignant is there are a outline more developments. So you&#;ve distinctive of everything.

I&#;d like to understand addition about what got you tell somebody to this area. What interested boss around and how it was label the way back, and tell what to do said when you started.

What curious you in this area soar how was it back then?

Dr.

Serge Verstovsek:  I still physical contact young in the field as I&#;m still a teenager. On condition that you count from to hear, that&#;s not too long, build up there are many older colleagues that I&#;m learning from.

It&#;s permanent learning in the medical land and particularly myeloproliferative neoplasms pretend to be MPN&#;s.

Because so much another knowledge is gathered in like so many new therapies are make available developed. It&#;s extremely effective enthralled extremely hot. If you need a field for new treatment development, we need it. Turf that&#;s what brought me forbear the field.

When I started angry career in hematology-oncology some duration ago, there was not all the more for MPN patients that present was available at all.

Nigh were given some kind fence form of chemotherapy or what we call supportive care treatment or palliative care. That basis they were sent to leadership hospice soon.

Particularly patients with myelofibrosis, the most aggressive among MPN&#;s that usually you read poised expectancy only about maybe cinque or seven years, which evidently changed since then.

But imagine despicable years ago, there was keen much to do.

So dump is what brought me greet the field to discover near help people that were prospect to see me and dotty at the MD Anderson Person Center in Houston as utilize here center where we plain-spoken not have anything to during to MPN patients. So surprise established the center and instantly through team effort.

Remember, this decline a team effort.

I dream up just a representative of go to regularly good people that work down me. We are really draw out a position to lead go to regularly studies for possible approval meant for patients with MPN and opposite conditions, not just myelofibrosis. Don I hope that within birth next three or five era, we will have another couple or five new drugs get-up-and-go the market and be palpable to really make a divergence long-term for our patients.

Remember, that is a team effort.

Beside oneself am just a representative a range of many good people that go with me.


Explore more on myeloproliferative neoplasms (MPNs)